Immune response (Ir) l genes associated with the murine major histocompatibility complex (H-2) have been shown to control cellular and humoral responses to determinants on numerous T cell-dependent antigens including simple synthetic amino acid copolymers (1-2) and complex natural proteins (3) (4) (5) (6) . In view of these findings and the relevance of the immune response to the pathogenesis of hepatitis B virus (HBV) infection and current vaccine programs, our laboratory has been investigating the role of Ir genes in regulating the immune responses to antigenic determinants of hepatitis B surface antigen (HBsAg) particles. HBsAg is a large (2.5-3.5 × l0 p mol wt) complex antigen possessing a common group-specific determinant, designated a, and two sets of subtype-specific determinants, d/y and w/r. The protein component is primarily composed of 25,000 D (25 kD) protein and 30 kD glycoprotein polypeptide subunits with identical amino acid sequences (7) .
We have previously demonstrated that the humoral immune responses to the group-specific a and subtype-specific d and y determinants of HBsAg are controlled by H-2-1inked Ir genes (8) . High responder (H-2q'd), intermediate to low responder (H-2 a> b> k), and nonresponder (H-2 s'f) hapiotypes have been identified (9) . The influence of an Ir gene(s) mapping in the I-A subregion on the primary antibody responses to both the a and d determinants of HBsAg and an additional influence of a gene(s) mapping to the right of the I-E subregion on at least the secondary anti-d response have been previously reported (8) . In this paper, we have investigated the kinetics and specificity of in vivo antibody production in additional congeneic, H-2-recombinant strains immunized with HBsAg of the ad and ay subtypes in order to further delineate the map positions of the relevant Ir genes and their influence on the immune response to distinct antigenic determinants on HBsAg.
This current analysis indicates that the humoral anti-HBs response is regulated by at least two H-2-1inked, Ir genes designated Ir-HBs-1, mapping in the I-A subregion, and Ir-HBs-2, mapping in the I-C subregion (right of I-E and left of H-2D). A gene(s) mapping in the I-A subregion regulates the primary responses to all HBsAg determinants, whereas the influence of the I-C subregional gene(s) appears to be determinant specific, primarily affecting the response to the d and 3' subtype-specific determinants of HBsAg. The anti-a response is regulated exclusively by Ir-HBs-1. Strains possessing only the Ir-HBs-2 gene produce no anti-a response, and a subtype-specific antibody response is detected only after secondary or tertiary immunization. In contrast, the influence of Ir-HBs-2 in the presence of Ir-HBs-1 is detected upon primary immunization and is additive rather than exclusive. There is also suggestive evidence that the presence of the E k molecule, at least in the context of I-A k, may have a suppressive influence on the anti-HBs response. These data indicate that, although the I-A subregion exerts a dominant influence, distinct Ir genes, mapping in separate I subregions, control immune responses to alternate HBsAg determinants on the same protein molecule.
In addition, the previous finding that HBsAg nonresponsiveness can be circumvented by conjugation of HBsAg to a carrier moiety suggested the expression of Ir-HBs genes in helper T cell function (10) . Herein, we have initiated analysis of the proliferative T cell responses to HBsAg in responder, nonresponder, and (responder × nonresponder)F~, H-2 congeneic strains and confirmed H-2 restriction of HBsAg-specific T cell proliferation. The kinetics and specificity of T cell proliferative responses paralleled in vivo antibody production.
Materials and Methods
Mice. C57BL/10 Sn (B10), B10.S(7R), B10.S(9R), B10.A(2R), B10.A(4R), B10.A(5R), B I 0.BR, D2.GD, A/J, A.TH, and A.TL murine strains were obtained from the breeding colony at the Research Institute of Scripps Clinic. B10.T(6R) and B10.HTT mice were provided by Dr. Hugh McDevitt of Stanford University, Palo Alto, CA and B10.S(8R), B10.RSF1, and A.AL mice were provided by Dr. Chella David of the Mayo Clinic, Rochester, MN. Female mice between 6 and 8 wk of age at the initiation of the experiments were used in all studies.
HBsAg Preparations. Preparations of HBsAg pooled from (ad) or (ay) donors were purified by a combination of ultracentrifugation, ammonium sulfate precipitation, pepsin digestion, and gel chromatography. Since these are pooled HBsAg preparations, other subtype-specific determinants (ie., w/r) would be expected to be present. However, upon immunization, these preparations have elicited anti-a and anti-d or -y responses only. This may result from the immunization dose, although the absence of anti-w or -r responses in guinea pigs immunized with HBsAg subtypes has previously been described (11) . The HBsAg preparations were free of contaminating human serum proteins as tested by Ouchterlony analysis and immunoelectrophoresis against goat anti-human serum.
hnmunizations. To study in vivo antibody production, groups of six mice were immunized by intraperitoneal injection of 4.0 t~g of HBsAg in 0.2 ml complete Freund's adjuvant (CFA) on day 0. They were bled from the retroorbital plexus on days 10 and 24, boosted identically on day 30, and bled again 14 d after secondary immunization (2°).
In vivo priming for the lymph node proliferative assay was accomplished by injection of a total of 16.0 #g of HBsAg in CFA in a volume of 80 #i into the two hind footpads of recipient mice.
Measurement ofln Vivo Anti-HBs Production. Serum antibody responses to HBsAg were measured by two methods. Pooled murine sera were evaluated for anti-HBs in an indirect, HBsAg subtype-specific, immunoglobulin class-specific, radioimmunoassay (RIA) using solid-phase HBsAg (ad or ay subtype) goat anti-mouse IgG and developed with a '251-labeled, affinity-isolated swine anti-goat Ig (SAGG -a~SI). The methodology, specificity, and sensitivity of this solid-phase RIA have been previously described (8, 9) . Titers are expressed as the reciprocal of log2 of the highest serum dilution to yield 2.5 times the counts of preimmunization sera. To analyze single murine serum samples for anti-HBs, a hemagglutination (HA) system was used. Human type O, Rh-negative erythrocytes were coated with HBsAg (ad or ay subtype) by the CrCls method (12) and added to 0.025 ml of serially diluted test sera in microtiter V-bottom plates. Results were expressed as the reciprocal of log,, of the highest serum dilution to yield agglutination. All anti-HBs assays were performed in 5-10% normal human serum to neutralize any possible antibodies to contaminating human plasma proteins that may not have been removed from the HBsAg preparation by the purification procedures.
Pooled serum samples of strains demonstrating a fourfold difference in anti-HBs titer as measured by RIA were uniformly found to be significantly different (P < 0.01) when individual serum HA titers of these strains were compared using the Student t test. Therefore, a fourfold difference in RIA anti-HBs titer was considered statistically significant.
Lymph Node Proliferation Assay. An HBsAg subtype-specific proliferation assay using draining popliteal lymph node cells was modified from the method of Corradin and Chiller (13) as described previously (10) . Briefly, mice were immunized in the hind footpads with 16 #g of HBsAg in CFA and draining popliteal lymph node (PLN) cells were harvested 8 d postimmunization. 4 × 105 viable unfractionated PLN cells in 0.1 ml of Click's media (14) modified by the addition of Hepes (10 raM), gentamycin (10 #g/ml), and 0.5% syngeneic mouse serum were placed in flat-bottom microtiter wells (Falcon 3072; Falcon Labware, Oxnard, CA) with 0.1 ml of HBsAg of the ad or ay sybtype (1.0-0.025 #g/ml) or culture media. Cultures were incubated for 5 d at 37°C in a humidified atmosphere of 5% COs in air and pulsed with 1 uCi [3H]thymidine (6.7 Ci/mmol; New England Nuclear, Boston, MA) 16-18 h before harvesting; proliferation was assessed by incorporation of 3H into DNA. The data are expressed as: stimulation index (SI) --cpm test antigen/cpm media control. The HBsAg-specific proliferative response of unfractionated PLN cells harvested from 5 to 12 d postimmunization was previously shown to represent antigen-specific T cell proliferation (10) .
To determine the effect of monoclonal anti-I-A reagents on T cell proliferation, HBsAgprimed, nylon column-passed PLN T cells (4 × 105) were cultured with HBsAg-pulsed, syngeneic, irradiated (2,500 rad) spleen cells (antigen-presenting cells) in the presence of various dilutions of anti-I-A reagents. MK-D6 (anti-I-A a) and MK-S4 (anti-l-AS), originally from Kappler and Marrack (15) were generously provided by Dr. J. A. Berzofsky, National Institutes of Health.
Results
Complex Region Gene Control of the Anti-HBs Response. Regulation of the immune response to the group-specific a determinant of HBsAg has been tentatively mapped to the I-A/I-B subregion of the H-2 complex, and evidence has been suggested that additional I subregional loci may influence the secondary subtypespecific d response (8) . To further delineate I region gene control, the kinetics and specificity of in vivo antibody production after HBsAg immunization has been analyzed in a number of congeneic, H-2-recombinant strains. Groups of six mice of each strain were immunized intraperitoneally with either 4.0 #g of DISTINCT Titers are expressed as the reciprocal of the Iog~ of the highest serum dilution to yield 2.5 times the counts of preimmunization sera. Only positive sera were pooled for RIA determination; unless otherwise noted (i.e., %), 100% of individual sera were positive by HA before pooling. The relevant major histocompatibility complex region and subregion allele of each strain are shown.
with HBsAg/ad or HBsAg/ay, respectively, was observed. In response to HBsAg/ ad immunization, the B10.HTT strain differed only slightly from the B10.S(9R) strain, with a fourfold lower secondary anti-d response in 50% of the recipients (Fig. 1 ). However, with respect to the anti-y response, the B10.HTT strain was totally nonresponsive after three HBsAg/ay immunizations, whereas 50% of the B10.S(9R) strain responded to the third immunization with an anti-y response ( Figs. 1 and 2) . Note also the B10.S(8R) strain, similar to all strains that produce an a-specific response, demonstrated an antisubtype response of greater magnitude than the group-specific anti-a response at all time points. The B 10.S(8R) strain results indicate that a responder allele in I-A/I-B is sufficient to confer responsiveness to all HBsAg determinants after primary immunization. Similarly, the D2.GD strain (not congeneic to B10) possesses the same I-E b, I-C b subregional loci as the nonresponding B 10.RSF 1 strain. However, the presence of the I-Ad/I-B ~ subregion produced a characteristic high responder phenotype (10 d, IgG, anti-a and anti-d) indicating the dominant influence of the I-A/I-B subregion on the anti-HBs response (Fig. 3) . Most likely the relevant Ir gene(s) maps to the I-A rather than the I-B subregion since monoclonai anti-I-A of the appropriate specificity significantly inhibits the y-and a-specific T cell proliferative responses in BALB/c mice ( Table I ). Note that the anti-I-A e monoclonal supernatant (MK-D6) quantitatively inhibited both the group-specific a and the subtype-specific y proliferative responses, but that a-specific proliferation was inhibited to a greater extent. Therefore, in the case of the BALB/c strain (H-2d), an I-Ad-encoded molecule(s) is relevant to both a-and y-specific T cell responses. Comparison of the A.TH and A.TL strains illustrates the irrelevance of the H-2K region since both strains possess the H-2K ~ region and the A.TL strain is an HBsAg responder, whereas the A.TH strain is a nonresponder (Fig. 4) . The A.AL and A.TL strains were compared because part of the A, polypeptide chain of the A molecule in the A.TL strain is of H-2' haplotype (nonresponder) origin rather than H-2 k haplotype origin due to a possible intragenic recombinant event (16) , and it was of interest to determine if the derivation of the A~ polypeptide component of the I-A-encoded A molecule influenced the anti-HBs response. As shown in Fig. 4 , the A.AL and A.TL strains were not significantly different in their responses to the a or d determinants of HBsAg, suggesting that a determinant on the Ae or nonrecombinant part of the A~ polypeptide chain is associated with the recognition of HBsAg. (Fig. 3) . The B 10.A(2R) strain (I-C d) produced an eightfold greater 24-d primary anti-d response than the B10.BR strain (I-Ck). The secondary antid response of the B10.A(2R) strain was also eightfold higher than that of the B 10.BR strain. The primary anti-a response was not influenced by the I-C d allele, but the B10.A(2R) secondary anti-a response was fourfold greater than that of the BI0.BR strain. Previous studies of in vivo anti-HBs production in the C3H and CBA strains (9) and the response of the B10.BR H-2 congeneic strain indicate that the H-2 k haplotype confers low responsiveness to HBsAg. However, the B10.S(8R) and B10.A(4R) strains produced 16-fold greater primary anti-d responses than the B10.BR strain (Figs. 1 and 3) . Like B10.BR, these strains possess the I-A k subregion, but unlike B10.BR, they do not express an E k molecule. These results suggest the possibility that I-E k, at least in the context of I-A k, may be suppressive. If expression of an E k molecule is suppressive, it appears that an Ee k chain is required, since the B10.A(5R) strain (I-A b, I-E k) produces a vigorous primary and secondary anti-HBs response (Fig. 3) . It should be noted that the B10.S(8R) and B 10.A(4R) strains also lack the I-C k subregion as compared with the B10.BR strain; possession of I-C k cannot be ruled out as possibly relevant to the "inferior" B10.BR response. HBAg/ad concentrations from 0.05 to 1.0 #g/ml and required 10-fold higher HBsAg/ay doses to induce significant a-specific proliferation, which was consistently of lower magnitude (Fig. 5). In contrast, .BR strains, which share the I-E k allele, illustrate the relevance of the I-C subregion, it cannot be assumed that additional mechanisms are not operative in strains differing at I-E. For example, the presence of I-E krestricted T suppressor cells in the lactate dehydrogenase B system was recently demonstrated (19) . The observations of ~50% responsiveness in strains possessing a responder allele in I-C in the context ofa nonresponder allele in I-A [B10.S(9R), B10.HTT] is difficult to assess. We have observed this heterogeneity in two different H-2-recombinant strains involving a total of 33 mice in response to two separate antigens (d and y) and suggest it may be more than artifactual. Evidence for classifying these strains as responsive to HBsAg comes from the fact that upon further hyperimmunization, at least minor antisubtype responses are observed in virtually 100% of mice as well as low titer anti-a responses in some mice. A similar observation has been made in the sperm whale myoglobin (Mb) system, involving the B10.HTT strain, wherein it was suggested that nonresponse was more likely an artifact than response and that the strain was considered responsive (20) . We are currently conducting genetic analysis of (9R) responder and (9R) nonresponder mice to resolve this issue. In any event, the validity of the concept of dual Ir gene control does not rely solely on the response status of the B 10.S(9R) and B10.HTT strains, as discussed previously.
Influe~zce of the I-A a~d I-C Subregions on the Anti-HBs/ad Responses in H-2 Recombinant Strab~s on an
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Relevance of the I-C Subregion on Anti-HBs/ad Responses in H-2 Recombinant Strains on a BIO Genetic Background and Possible Negative Influence of the I-E*/I-C k Subregion. Comparison of in vivo anti-HBs/ad production between B10.BR and B10.A(2R) strains, which differ significantly only in the I-C subregion (H-2D irrelevant), confirmed that a gene(s) influencing the anti-d response maps to the I-C subregion

H-2 Restriction of T Lymphocyte Proliferative Responses to the a and d Determinants of
Cumulatively, these genetic data clearly indicate the existence of at least two H-2-1inked Ir genes regulating the response to HBsAg determinants, one mapping in the I-A subregion and the other in the I-C subregion. It should be noted that we provide no formal evidence that gene(s) to the right of I-C and to the left of H-2D are not involved in regulation of the response to HBsAg, and use the term "I-C subregion" in this broad sense. However, a question arises as to whether the gene(s) mapping in the I-C subregion (Ir-HBs-2) effects the anti-a response as well as the anti-d/y responses, since the I-C subregion allele appeared to influence the anti-a response in certain recombinant strains. We suggest that Ir-HBs-2 does not directly regulate the anti-a response because: (a) no anti-a responses are detected in the absence of Ir-HBs-1; (b) the presence of the high responder I-C d allele did not affect the anti-a response in all recombinant strains and; (c) anti-I-A ~ monoclonal antibody incompletely inhibited the y-specific T cell proliferative response of BALB/c (H-2 d) mice possessing both Ir-HBs genes, but totally abrogated the anti-a-specific proliferative response, suggesting that the anti-a response is exclusively restricted by the I-A subregion. The apparent influence of the I-C subregion on the anti-a response may reflect T cell helper activity directed to the d or y determinants that nonspecifically amplifies the antia response.
Although these genetic experiments were analyzed by measuring in vivo antibody production, the T cell proliferative responses to the a and d determinants of HBsAg were H-2-restricted and the kinetics and specificity of the T cell responses paralleled those of in vivo antibody production. For example, the dspecific proliferative responses preceded and were of greater magnitude than the a-specific proliferative responses: In addition, the responses of the (R x NR)FI mice indicated that HBsAg-specific T cell proliferation is inherited as a dominant trait with no gene dosage effects as observed for antibody production (9) . These results, the T dependent nature of HBsAg (21) , and the fact that nonresponsiveness to HBsAg can be circumvented by conjugation to a carrier moiety (10) establish that lr-HBs genes are expressed at the T cell level.
The regulation of the immune response to HBsAg bears some remarkable similarities with other Ir gene-restricted, naturally occurring, protein antigens. The immune response to hen egg lysozyme (HEL) is controlled by two Ir gene loci, one in the I-A and the other believed to be in the I-C subregion (22) . Differential effects between I-C d and I-C k alleles in the HEL system have been reported as well (23) . The murine antibody and T lymphocyte proliferative response to Mb were found to be under the control of two distinct H-2-1inked Ir genes, one mapping in the I-A subregion (Ir-MB-1) and the other mapping in the I-C subregion (Ir-Mb-2) (24). Furthermore, H-2-recombinant strains possessing only the Mb responder allele in I-A were responsive to all cyanogen bromide cleavage fragments, whereas strains possessing only the Mb responder allele in I-C responded to the NH2-terminal fragment but not to the COOH-terminal fragment, and these responses were evaluated after secondary or tertiary immunization (24) . Therefore, similar to the HBsAg system, the I-A responder allele confers full responsiveness to Mb, and the I-C responder allele in the absence of an I-A responder allele confers responsiveness to fewer or a subset of determinants.
Any hypothesis regarding the relationship of I-A and I-C subregional loci and their influence on the regulation of responsiveness to a multideterminant, protein antigen such as HBsAg must explain the predominant influence of the I-A subregion on responses to all determinants coexistent with the influence of the I-C subregion on the responses to the subtype-specific determinants. Multiple independent Ir genes mapping in I-A that regulate the a, d, and y responses seem unlikely in view of the fact that H-2 s'r hapiotype-bearing strains are nonresponsive to all HBsAg determinants. The I-C subregion may encode immune suppressor genes. Such a role for the I-C subregion in the control of the generation of suppressor T cells (Ts) in the mixed lymphocyte reaction has been proposed (25) . Additionally, I-C subregion-encoded suppressor factors have been reported to regulate lymphokine production (26) and contact sensitivity (27) . Although nonresponders to HBsAg can be induced to produce anti-HBs in vivo by alteration of the route as well as dose of immunization, we have been unable to demonstrate a role for Ts cells in HBsAg nonresponsiveness (10) . However, we are continuing to explore this possibility as it may apply to the influence of the I-E/I-C subregions. Regarding the influence of the I-A subregion, an hypothesis consistent with existing data predicts the existence of a T cell "carrier determinant" on HBsAg, recognized by helper T (Th) cells in the context of an Ia molecule encoded within the I-A subregion. Such Th cells may be able to provide functional help to B cell clones specific for the a, d, and y epitopes. There is increasing evidence that T cell determinants on a molecule can be distinct from B cell determinants or antibody-binding sites in a variety of antigen systems including, glucagon (28) , insulin (29), 13-galactosidase (30), lysozyme (31), myoglobin (32) , and the encephalomyelitogenic, myelin basic protein peptide (33) . In this regard, immunization of mice (10) and rabbits (18) with keyhole limpet hemocyanin-conjugated synthetic peptide analogues of HBsAg determinants induced significant anti-HBs responses. In contrast, immunization of mice with free synthetic peptide analogues of the d and y determinants of HBsAg induced minimal antibody responses and did not distinguish H-2 q from H-2 s haplotypebearing strains (10) . These data suggest that these synthetic B cell epitopes do not possess T cell determinants, and therefore, Ir-restricted, T cell helper activity is absent. Indeed, evaluation of the immune response to chemically synthesized peptide fragments of HBsAg suggests the existence of distinct T and B cell epitopes on HBsAg (manuscript in preparation). With respect to native HBsAg, a responder allele in I-A may result in carrier-specific help engaging all determinant-specific B cell clones. The concept of a T cell carrier determinant on HBsAg need not exclude the existence of determinant-specific Th or Ts cells specific for d or y determinants and restricted by the I-E/I-C subregion. The presence of a nonresponder allele in I-A would preclude carrier-specific help and may necessitate secondary or tertiary immunization to expand smaller d/y determinant-specific T cell precursor pools, which may selectively cooperate with determinant-specific B cell clones. Strains possessing both Ir-HBs genes would reflect an additive rather than exclusive effect of Ir-HBs-2.
The difficulties in demonstrating I-C-encoded, serologically detectable molecules have prompted questioning of the existence of the I-C subregion (34) . However, the recent demonstration of xenoantisera that detect I-C d-and I-C bencoded products (35) and the observation that at least three Ir gene-restricted, multideterminant, naturally occurring protein antigens are influenced by genes mapping in the I-C subregion clearly support the existence of an I-C subregion. The consistent involvement of the I-C subregion and the similarities of the regulation of the immune response to these protein antigens suggest a unique influence of this subregion on responses to naturally occurring protein antigens that may not be relevant to simple copolymer antigens.
The results of these investigations raise several questions regarding the mechanism of responsiveness to HBsAg. How do distinct Ir genes regulate the response to different determinants on the same molecule? What is the nature of the determinant(s) recognized by T helper cells and B cells? What is the mechanism of I-C subregion influence? In addition, the evidence of multiple I-region gene control of the murine immune responses to HBsAg provides a model to more adequately understand the complex and variable human immune responses to HBsAg after vaccination as well as during the course of HBV infection. In this regard, it is notable that an association between HLA-DR phenotype and nonresponsiveness to a trial HBsAg vaccine has been reported (36) , and a human HBsAg vaccine recipient was observed to produce an anti-d response in the absence of an anti-a response (37) . These preliminary findings suggest that, after immunization, distinct Ir genes may influence regulation of the human immune response to the a and d determinants of HBsAg, as demonstrated herein for the murine immune response.
Summary
We have previously demonstrated that the murine humoral immune responses to the group-specific a and subtype-specific d/y determinants of hepatitis B surface antigen (HBsAg) are controlled by H-2-1inked immune response (Ir) genes. High responder (H-2d'q), intermediate responder (H-2 a > b > k) and nonresponder (H-2 r's) haplotypes have been identified (8, 9) . The kinetics and specificity of in vivo antibody production after HBsAg immunization in congeneic, H-2-recombinant strains was analyzed to further define relevant Ir genes and their influence on the immune response to distinct antigenic determinants.
These studies indicate that the humoral anti-HBs response is regulated by at least two Ir genes, one in the I-A subregion (Ir-HBs-1) and one in the I-C subregion (Ir-HBs-2) of the murine H-2 complex. Ir-HBs-1 regulates the primary responses to all HBsAg determinants, whereas the influence of Ir-HBs-2 is determinant specific, affecting the responses to the d or y determinants. The anti-a response is regulated exc_lusively by Ir-HBs-1. Strains possessing only the Ir-HBs-2 gene [B10.S(9R) and B10.HTT] produce no anti-a response and a subtype-specific antibody response is detected only after secondary or tertiary immunization. In contrast, the influence of Ir-HBs-2 in the presence of Ir-HBs-1 is detected upon primary immunization and is additive rather than exclusive. There is also suggestive evidence that the presence of the E k molecule, at least in the context of I-A k, may have a suppressive influence on the anti-HBs response. Additionally, HBsAg-specific, T cell proliferative responses were H-2 restricted and the kinetics and specificity of T cell proliferative responses paralleled in vivo antibody production. These data indicate that, although the I-A subregion exerts a dominant influence, distinct Ir-HBs genes, mapping in separate I subregions, control immune responses to alternate HBsAg determinants on the sameprotein molecule.
